At Castle Dermatology Institute, we are one of the only offices in the area to offer the XTRAC laser treatment for psoriasis, vitiligo, and some forms of eczema. This laser is a form of narrow-band UVB (NBUVB) light treatment. Unlike traditional NBUVB therapies where patients would need to stand in a booth, this treatment uses a hand-held laser light beam to carefully target patches of skin that are affected by psoriasis or vitiligo, as well as by eczema. Because XTRAC delivers a highly targeted, therapeutic beam of UV llight only to areas of the affected skin, healthy skin surrounding the lesions stays that way. 

XTRAC clears the symptoms, prolongs the remission and returns skin to a clinically healthy state in record time. If medications, creams, and other lifestyle and dietary changes haven’t worked for you, Xtrac laser therapy may be the solution. You can even receive Xtrac laser therapy treatment while pregnant, nursing, or on any of a variety of prescription medications.

What You Need to Know About Xtrac
Xtrac laser therapy requires multiple sessions to be effective. For most patients, ten to twenty sessions—each lasting approximately 5 minutes—is enough to effectively clear an affected area. These sessions usually take place between one-to-three times a week, depending upon your skin type and severity of condition.

Xtrac laser therapy does not hurt, and no recovery time following treatment is required. This means that no anesthesia, general nor local, is required with Xtrac therapy, reducing the procedure’s associated risks.

Following the treatment, a feeling of being sunburnt—characterized by redness, itching, and tenderness—may result. Xtrac laser therapy, while effective, is not totally without risks. If you have a family history of skin cancer, make sure you discuss this with your dermatologist prior to receiving treatment. Xtrac laser therapy may increase the risk of developing non-melanoma type skin cancers.

Most health insurance and Medicare plans cover the treatment costs of Xtrac laser therapy.